By Ben Hirschler and Kate Kelland – The drugs don’t work – and neither does the market, when it comes to antibiotics.
When sophisticated bugs that medicines used to kill within days start to fight back and win, all of healthcare, and the people it keeps alive, is in trouble.
“This is…not a science issue. This is an issue of markets and economics,” said Britain’s chief medical officer Sally Davies. “A scientist would just get bogged down and not get it.”
The key challenge is how to reward companies for finding drugs like Sirturo that must be used as sparingly as possible to avoid resistance developing – in effect, breaking the traditional link between payment and prescription volume. more> http://tinyurl.com/p5xlq32